STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $203,000 | +73.5% | 42,026 | +282.4% | 0.00% | – |
Q4 2019 | $117,000 | -81.6% | 10,990 | -82.0% | 0.00% | -100.0% |
Q3 2019 | $636,000 | +198.6% | 61,088 | +339.6% | 0.00% | – |
Q2 2019 | $213,000 | +113.0% | 13,895 | +79.6% | 0.00% | – |
Q1 2019 | $100,000 | -86.5% | 7,735 | -90.1% | 0.00% | -100.0% |
Q4 2018 | $741,000 | +23.7% | 77,957 | +116.2% | 0.00% | 0.0% |
Q3 2018 | $599,000 | +84.9% | 36,060 | +78.2% | 0.00% | – |
Q2 2018 | $324,000 | -13.4% | 20,231 | -17.3% | 0.00% | – |
Q1 2018 | $374,000 | +4055.6% | 24,458 | +4175.9% | 0.00% | – |
Q4 2017 | $9,000 | +800.0% | 572 | +717.1% | 0.00% | – |
Q3 2017 | $1,000 | -50.0% | 70 | -71.1% | 0.00% | – |
Q2 2017 | $2,000 | -60.0% | 242 | -61.6% | 0.00% | – |
Q1 2017 | $5,000 | +66.7% | 631 | +166.2% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 237 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | +50.0% | 237 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -96.8% | 237 | -98.2% | 0.00% | – |
Q1 2016 | $62,000 | +3000.0% | 13,317 | +3011.4% | 0.00% | – |
Q4 2015 | $2,000 | -50.0% | 428 | -8.9% | 0.00% | – |
Q3 2015 | $4,000 | -71.4% | 470 | -60.4% | 0.00% | – |
Q2 2015 | $14,000 | -78.8% | 1,186 | -73.7% | 0.00% | – |
Q1 2015 | $66,000 | -38.3% | 4,507 | -27.6% | 0.00% | – |
Q4 2014 | $107,000 | +78.3% | 6,226 | +30.5% | 0.00% | – |
Q3 2014 | $60,000 | -15.5% | 4,770 | -0.7% | 0.00% | – |
Q2 2014 | $71,000 | -41.8% | 4,805 | -19.3% | 0.00% | – |
Q1 2014 | $122,000 | +87.7% | 5,951 | +78.6% | 0.00% | – |
Q4 2013 | $65,000 | +6400.0% | 3,332 | +27666.7% | 0.00% | – |
Q3 2013 | $1,000 | -80.0% | 12 | -94.6% | 0.00% | – |
Q2 2013 | $5,000 | – | 222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|